AbbVie Inc. (ABBV) — Stock Price, Chart & Analysis
AbbVie Inc. (ABBV) is a Healthcare stock currently trading at $100, up 0.00% on the day. It carries a market capitalization of $434.78B and a trailing P/E ratio of 68.92. Over the past 52 weeks, ABBV has traded between $190.75 and $267.47. AbbVie Inc. pays a dividend yielding 2.8%. View the live ABBV chart, technical opinion, analyst ratings, fundamentals and latest news below.
AbbVie Inc. (ABBV) key data
| Price | $100 |
| Change (today) | +0.00% |
| Previous close | $100 |
| Market cap | $434.78B |
| P/E ratio (TTM) | 68.92 |
| EPS (TTM) | $3.57 |
| Dividend yield | 2.8% |
| 52-week high | $267.47 |
| 52-week low | $190.75 |
| Beta | 0.28 |
| Avg. volume | 6.82M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
Frequently asked questions about AbbVie Inc. (ABBV)
How much does one share of AbbVie Inc. cost?
As of the latest update, one share of AbbVie Inc. (ABBV) trades at $100 (+0.00% today).
What is AbbVie Inc.'s market cap?
AbbVie Inc. has a market capitalization of approximately $434.78B.
What is AbbVie Inc.'s P/E ratio?
AbbVie Inc. has a trailing price-to-earnings (P/E) ratio of 68.92.
What is AbbVie Inc.'s earnings per share (EPS)?
AbbVie Inc.'s trailing twelve-month EPS is $3.57.
Does AbbVie Inc. pay a dividend?
Yes — AbbVie Inc. pays a dividend with a yield of 2.8% ($6.92 per share annually).
What is AbbVie Inc.'s 52-week trading range?
Over the past year, ABBV has traded between $190.75 and $267.47.
What is the analyst price target for AbbVie Inc.?
The mean analyst price target for AbbVie Inc. is $273.39. This is informational only and not investment advice.
Latest AbbVie Inc. (ABBV) news
- AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026?News · Aug 7, 2026
- AbbVie (ABBV) Is Down 5.3% After Raising 2026 Revenue Outlook and Issuing New Debt - What's ChangedNews · Aug 7, 2026
- The Two Divergent Paths Priced Into Eli Lilly StockNews · Aug 7, 2026
- Ironwood Q2 Earnings Beat Estimates, Revenues Lag, 2026 View RaisedNews · Aug 7, 2026
- These New Drugs Could Fuel Fresh Highs for Biotech and Pharma StocksNews · Aug 7, 2026
- REGENXBIO Q2 Earnings Call HighlightsNews · Aug 7, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live ABBV dashboard…